Wird geladen...
Risk factors with the development of infection with tigecycline- and carbapenem-resistant Enterobacter cloacae
BACKGROUND: Tigecycline is regarded as a last resort treatment for carbapenem-resistant Enterobacter cloacae (CREC) infections, and increasing numbers of tigecycline- and carbapenem-resistant E. cloacae (TCREC) isolates have been reported in recent years. However, risk factors and clinical impacts o...
Gespeichert in:
| Veröffentlicht in: | Infect Drug Resist |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6430992/ https://ncbi.nlm.nih.gov/pubmed/30936728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S189941 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|